KAYLA HOLLOWAY: Open Payments
NPI 1275909426 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 61 payments from 14 companies in 2025. Trend: 2023 $870 · 2024 $1,638 · 2025 $1,174
Food & beverage: $1,163Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $333 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $173 |
| Medtronic, Inc. | 3 | $152 |
| Janssen Biotech, Inc. | 6 | $128 |
| Gilead Sciences, Inc. | 6 | $116 |
| Ardelyx, Inc. | 6 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Ipsen Biopharmaceuticals, Inc | 2 | $38 |
| EVOKE PHARMA, INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
Products named: RINVOQ, ENTYVIO, INTERSTIM, TREMFYA, SKYRIZI, IBSRELA, XIFAXAN, IQIRVO.
Industry payments across GA — which companies pay providers there.
